Xaar 1Q09 trading resilient; balance sheet strong

Xaar plc, the inkjet printing technology group HQed in Cambridge, said trading for the first quarter of the year was in line with the Board's expectations at a level similar to that for Q1 2008 and of the second half of 2008.

The Board said it was encouraged but, given both a continuing lack of visibility of customer orders and the current uncertainty in the business environment due to the ongoing global economic situation, must remain cautious when looking forward.

The company said the first of its new second generation Platform 1 products, the Proton, was successfully launched during the period at the Sign China show in Guangzhou.

Sales of the Proton into China have been ahead of expectations. It will be released into India and Latin America during this year as the Group's OEM customers in those regions launch new printing machines incorporating the printheads. The Xaar Electron, the second new Platform 1 product, remains on course for launch in customer printing machines at the Shanghai Ad show in early July.

Original Equipment Manufacturers in western markets continue to launch printing machines based on Xaar's Platform 3(P3) technology with further product launches during the period.

Whilst the number of OEM customers bringing printing machines based on P3 technology to market is encouraging, the transition from product launch to volume sales remains slow and cannot be expected to be immune from the effects of the global economic situation, the company said.

The Group has maintained its strong balance sheet throughout the period with gross cash at end March of £12.4m (31 December 2008: £11.6m). Total debt at 31 March 2009 was £0.6m (31 December 2008: £0.6m). The cash inflow during the period reflects both stable trading and the benefits of previously announced cost saving measures.

In April Xaar announced the rationalisation of its manufacturing facilities which will involve the eventual closure of its plant in Stockholm, Sweden and the relocation of that manufacturing capability to the Group's manufacturing facility in Huntingdon, near Cambridge. This will take up to two years to complete and is expected to result in a substantial reduction in the cost base.

The share market liked what it heard. The share price gained 2% in morning trading. Xaar now has a market capitalisation of around £47m.

 



Previous articles
VNC offers 2-way remote control for mobile devices; CamiSemi launches new power charger chips
Brady boosts profit, revenue in 1H09; says ‘well placed’ for growth
Light Blue Optics raises $26m to speed development of miniature laser projector
Silicon Fen shorts: Xaar novel inkjet used to make LCD screen; Alizyme signs deal in Japan; Minster Pharma 1H07 strong cash position
Amino sees big improvement in results this year; shipments up 90%
CeNeS to raise £6.1m in share placing to prepare Phase III trials for its lead pain relief drug
Aveva records another year of strong growth in revenues, profits; outlook positive
Autonomy says it will beat 3Q earnings forecast on accelerating organic growth
Amino Technologies sees solid revenue growth but profit hit by weaker dollar
Briefs: Antitope signs deal with NKT Therapeutics, Amino, Optibase integrate set top IPTV boxes
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • TTP Group


Dr David Parnell
Founder and Director


TTP Group plc is the holding company for: The Technology Partnership plc - one of Europe's leading independent technology development and licensing companies, creating new business from advances in technology. TTP Venture Managers Ltd - which invests in early stage science and technology companies

[TTP Group's profile]


Top20 Index




Currently: 161